Pregnant and Postpartum Women’s Experiences and Perspectives on the Acceptability and Feasibility of Copackaged Medicine for Antenatal Care and PMTCT in Lesotho

listen audio

Study Justification:
– The study aimed to assess the acceptability and feasibility of a copackaged medicine delivery mechanism for antenatal care and prevention of mother-to-child transmission (PMTCT) in Lesotho.
– The goal was to improve PMTCT and antenatal care-related service delivery by evaluating the experiences and perspectives of pregnant and postpartum women.
Study Highlights:
– The study found that nearly all participants found the prepackaged medicines acceptable, although some modifications were suggested, such as reducing the size of the pack.
– Positive experiences included improved adherence to medication instructions and promotion of healthy pregnancies.
– Negative experiences included inadvertent pregnancy disclosure and discomfort carrying the pack in communities.
– Implementation of the copackaging mechanism was feasible, with the majority of participants reporting adequate counseling time.
– Some participants felt that the use of the pack caused clinic delays.
– Service quality improved following the introduction of the pack, due to more comprehensive counseling.
Recommendations:
– The study recommends continued use of the copackaging mechanism for ANC/PMTCT medicines in Lesotho.
– However, it suggests making design modifications to reflect the current PMTCT program of lifelong treatment for all HIV-positive pregnant women.
– The recommendations aim to address the issues raised by participants, such as the size of the pack and inadvertent pregnancy disclosure.
Key Role Players:
– Ministry of Health (MOH) in Lesotho
– Health care workers (HCW)
– Maternal and child health (MCH) study nurses
– Study coordinators and investigators
Cost Items for Planning Recommendations:
– Research staff salaries
– Training in qualitative research methods
– Data collection instruments
– Translation services
– Audio recording equipment
– Transcription services
– Data entry and verification system
– Statistical analysis software
– Ethical review process
– Travel expenses for study staff
– Communication and coordination costs

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is rated 8 because it provides a detailed description of the study design, methods, and findings. The study used a mixed method, cross-sectional design and conducted structured interviews (SI) and semistructured interviews (SSI) with pregnant and postpartum women in Lesotho. The study assessed the acceptability and feasibility of a copackaged medicine for antenatal care and prevention of mother-to-child transmission (PMTCT) of HIV. The findings indicate that nearly all SI participants found the prepackaged medicines acceptable, but modifications such as size reduction were suggested. Positive experiences included improved adherence to medication and promotion of healthy pregnancies, while negative experiences included inadvertent pregnancy disclosure and discomfort carrying the pack. Implementation was deemed feasible, with most participants reporting adequate counseling time, although some felt that pack use caused clinic delays. The study concludes that the prepackaged drug delivery mechanism is acceptable and feasible, but suggests design modifications to align with the current PMTCT program. To improve the evidence, the abstract could provide more specific details about the sample size, recruitment process, and data analysis methods. Additionally, it would be helpful to include the limitations of the study and recommendations for future research.

Objective. To improve PMTCT and antenatal care-related service delivery, a pack with centrally prepackaged medicine was rolled out to all pregnant women in Lesotho in 2011. This study assessed acceptability and feasibility of this copackaging mechanism for drug delivery among pregnant and postpartum women. Methods. Acceptability and feasibility were assessed in a mixed method, cross-sectional study through structured interviews (SI) and semistructured interviews (SSI) conducted in 2012 and 2013. Results. 290 HIV-negative women and 437 HIV-positive women (n = 727) participated. Nearly all SI participants found prepackaged medicines acceptable, though modifications such as size reduction of the pack were suggested. Positive experiences included that the pack helped women take pills as instructed and contents promoted healthy pregnancies. Negative experiences included inadvertent pregnancy disclosure and discomfort carrying the pack in communities. Implementation was also feasible; 85.2% of SI participants reported adequate counseling time, though 37.8% felt pack use caused clinic delays. SSI participants reported improvement in service quality following pack introduction, due to more comprehensive counseling. Conclusions. A prepackaged drug delivery mechanism for ANC/PMTCT medicines was acceptable and feasible. Findings support continued use of this approach in Lesotho with improved design modifications to reflect the current PMTCT program of lifelong treatment for all HIV-positive pregnant women.

This was a mixed method, cross-sectional study. Structured exit interviews (SI) and in-depth semistructured interviews (SSI) with pregnant and early postpartum women were conducted from December 2012 to May 2013. The study was conducted in six purposively selected districts out of the ten districts in Lesotho. Three districts were those selected by the MOH to first implement the mother/baby copackage. Three comparable districts with later initiation were selected to match the three geographical settings of Lesotho (Lowlands, Foothills, and Highlands) represented in the initial implementing districts. Within each district, health facilities (HF) were randomly selected as study sites using the probability proportional-to-size (PPS) method to ensure all HF had the same probability of being selected. SI were conducted in all 31 study sites while SSI were conducted in two study sites per district (highest volume hospital and health center) for a total of 12 sites. HIV-positive and HIV-negative women who were attending a subsequent ANC visit and 6-week and 14-week postnatal care (PNC) visits at study sites were eligible for participation in interviews. Health care workers (HCW) introduced the study and assisted in linking potential participants with study staff. Study staff attempted to conduct SSI with HIV-positive women who did not return to ANC or early PNC to capture their experiences with the copackage and any influences it may have had on their health-seeking behavior. We used the routine PMTCT program follow-up system to identify and trace women who had missed visits. When these women were found, the community or health worker introduced them to the study and invited them to speak with study staff at a convenient time and location. A sample of 196 women in each of the three groups (HIV-negative, HIV-positive on prophylaxis, and HIV-positive on ART) was targeted. We estimated 85% of women would find the intervention both acceptable and feasible, based on the MPP evaluation [15]. Assuming an expected proportion of 0.85, the large sample normal approximation was used to calculate a two-sided 95% confidence interval around the observed proportion with a margin of error of 0.05 to determine a needed sample size for SI of 196. The target sample per HF was determined using PPS based on routinely collected antenatal attendance program data. Women were selected through a random process by which they were consecutively referred and screened on days when study staff were present, until either the sample size at each HF was reached or the data collection period ended. HF targets were further divided into six subgroups of roughly equal numbers based on all possible combinations of visit type (ANC, PNC) and type of copackage received (Pack 1, Pack 2, and Pack 3). Once a subgroup target was reached, women in that particular group were no longer eligible. Trained maternal and child health (MCH) study nurses explained the study, obtained and documented verbal informed consent, and conducted SI using data collection instruments specifically designed according to the type of visit and type of copackage received. All interviews were conducted in Sesotho. SI involved closed-ended questions, including a series of seven copackage acceptability (e.g., size, convenience, and design) and eight copackage feasibility (e.g., counseling, understanding, and clinic flow) statements. Women were asked to indicate whether they agreed or disagreed or had no opinion for each statement. They were also asked to describe what they liked/disliked about the copackage and their positive/negative experiences related to its use. Interviewers selected precoded responses that best fit the women’s answers and documented other responses that could not be classified. SSI guides covered similar topics, but their open-ended nature allowed interviewers to probe more deeply. These interviews were intended to capture richer and more complex information than the SI. As such, a smaller approximate sample size range was estimated in order to reach saturation of theme: 9–15 HIV-positive women (with approximately equal targets for women on prophylaxis and ART) and 4–6 HIV-negative women per HF for a total of 108–180 and 48–72, respectively, with subgroup targets by visit type (ANC, 6-week PNC, 14-week PNC). SSI study staff were different from those conducting SI and were trained in qualitative research methods. Consecutive recruitment of women on days when study staff were present was similar to the SI process. If SI and SSI recruitment were taking place at the same HF on the same day, women were first approached to participate in the SSI; if they declined, they were asked whether they were willing to participate in the shorter SI. SSI were audio recorded and were simultaneously transcribed and translated into English. Transcripts were reviewed by the study coordinators and/or investigators once translated. Data from close-ended questions in SI and SSI were entered into a Microsoft Access database (2007) using a double data entry and verification system. Descriptive statistics were calculated and reported for key characteristics of the study participants and agreement with acceptability and feasibility statements and reported experiences. Means and standard deviations were reported for all continuous variables (Table 1) and frequencies and percentages were reported for all categorical variables (Tables ​(Tables11 and ​and22 and Figures ​Figures22 and ​and3).3). Differences in (1) the level of agreement with acceptability and feasibility statements and (2) the experience of either positive or negative consequences as a result of pack receipt among HIV-negative women, HIV-positive women on prophylaxis, and HIV-positive women on ART were examined with generalized estimating equations (GEE) using the binomial distribution with the logit link for dichotomous outcomes or the multinomial distribution with the cumulative logit link for ordinal outcomes. Select significant findings are highlighted in the text. Compound symmetry and independent working correlation structures were considered to account for the clustering of women in multiple facilities. Score tests were used to test the proportional odds assumption, and the Tukey-Kramer method for P value adjustment was used to account for multiple comparisons. All statistical tests were two-sided and the level of statistical significance was set at 0.05. All data were analyzed in Washington, DC, USA, using SAS/STAT software version 9.3 (Cary, North Carolina). Percentage of structured interview participants that agree with the copackage acceptability statements by HIV status group. (Possible responses to statements included agree, disagree, and no opinion. “No opinion” responses ranged from 0.4 to 2.0% of the three groups combined for each statement, except the instruction sheet statement, in which 13.7%, 24.8%, and 22.0% of HIV-negative, HIV-positive on prophylaxis, and HIV-positive on ART women responded with “no opinion,” because they did not have or did not use the sheet.) Percentage of structured interview participants that agree with the copackage feasibility statements by HIV status group. (Possible responses to statements included agree, disagree, and no opinion. For most statements, “no opinion” responses ranged from 0.6 to 7.0% of the three groups combined for each statement. The exceptions were “all questions about the pack were answered” in which 12.8%, 10.5%, and 8.5% of HIV-negative, HIV-positive on prophylaxis, and HIV-positive on ART women, respectively, responded with “no opinion,” at first visit and 16.1%, 13.2%, and 12.7%, respectively, responded with “no opinion,” at this visit (if interviewed in ANC) or subsequent visits (if interviewed in PNC) because they did not have questions.) Characteristics of study participants. ∗Excluded from the percentage calculation. Women’s positive and negative experiences with the pack reported in structured interviews. SSI transcripts were imported into MAXqda (V10). A codebook was created based on the research objectives and variables of interest. Data were coded by a team in the US and Lesotho and reviewed for consistency by one investigator. Textual data were carefully reviewed to identify recurrent patterns and themes and draw conclusions connected to the study questions. Data were summarized through descriptive, text-based summaries and data display matrices. Both deductive codes based on research questions and inductive codes derived from the data were utilized. This study was approved by the George Washington University Institutional Review Board (IRB), the Baylor College of Medicine Lesotho IRB, and the Lesotho MOH ethical review committee. All participants underwent a verbal informed consent process in Sesotho using an IRB-approved verbal consent text with documentation of consent by study staff.

Based on the information provided, here are some potential innovations that could be considered to improve access to maternal health:

1. Mobile health (mHealth) applications: Develop mobile applications that provide pregnant women with information and reminders about antenatal care visits, medication adherence, and healthy pregnancy practices. These apps can also facilitate communication between healthcare providers and pregnant women, allowing for remote consultations and support.

2. Community-based antenatal care: Implement community-based antenatal care programs where trained community health workers provide basic antenatal care services, including health education, monitoring of vital signs, and distribution of medication. This can help reach women who have limited access to healthcare facilities.

3. Telemedicine services: Establish telemedicine services that allow pregnant women to consult with healthcare providers remotely, reducing the need for travel and improving access to specialized care. This can be particularly beneficial for women in remote or underserved areas.

4. Integration of maternal health services: Integrate maternal health services with other healthcare services, such as family planning and HIV/AIDS care, to provide comprehensive care for pregnant women. This can improve efficiency and reduce the burden of multiple clinic visits for women.

5. Task-shifting and training: Train and empower non-physician healthcare providers, such as nurses and midwives, to provide certain aspects of antenatal care, such as routine check-ups and basic screenings. This can help alleviate the shortage of skilled healthcare providers and improve access to care.

6. Transportation support: Provide transportation support, such as vouchers or subsidies, to pregnant women who have difficulty accessing healthcare facilities. This can help overcome geographical barriers and ensure timely access to antenatal care.

7. Community awareness campaigns: Conduct community awareness campaigns to educate pregnant women and their families about the importance of antenatal care and the available services. This can help reduce stigma, increase demand for services, and improve overall maternal health outcomes.

These are just a few potential innovations that can be explored to improve access to maternal health. It is important to consider the local context and resources available when implementing these innovations.
AI Innovations Description
The recommendation from this study is to continue using the prepackaged drug delivery mechanism for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) medicines in Lesotho, with some design modifications. The study found that the copackaged medicine was acceptable and feasible among pregnant and postpartum women.

Some of the positive experiences reported by participants included the convenience of the pack, which helped them take pills as instructed, and the contents of the pack promoting healthy pregnancies. However, there were also negative experiences, such as inadvertent pregnancy disclosure and discomfort carrying the pack in communities.

To improve the copackaging mechanism, suggestions were made to reduce the size of the pack and address issues related to inadvertent pregnancy disclosure. Additionally, improvements in counseling and clinic flow were recommended to address concerns about clinic delays.

Overall, the study supports the use of the prepackaged drug delivery mechanism for ANC/PMTCT medicines in Lesotho, but with modifications to better align with the current PMTCT program of lifelong treatment for all HIV-positive pregnant women.
AI Innovations Methodology
Based on the description provided, here are some potential recommendations for improving access to maternal health:

1. Size reduction of the pack: Based on the feedback from the study participants, modifying the size of the prepackaged medicine pack could make it more convenient for pregnant and postpartum women to carry and use.

2. Improved design modifications: The study participants suggested that design modifications could be made to better align with the current PMTCT program. These modifications could include clearer instructions, better organization of the contents, and user-friendly packaging.

3. Addressing inadvertent pregnancy disclosure: Some women reported that carrying the pack in their communities inadvertently disclosed their pregnancy status. Finding ways to address this issue, such as discreet packaging or alternative delivery methods, could help protect women’s privacy.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the indicators: Identify key indicators that reflect access to maternal health, such as the number of women receiving antenatal care, the number of women receiving PMTCT services, and the timeliness of receiving these services.

2. Collect baseline data: Gather data on the current state of access to maternal health services, including the acceptability and feasibility of the existing copackaging mechanism. This could involve conducting surveys, interviews, and observations at healthcare facilities and in the community.

3. Develop a simulation model: Create a simulation model that incorporates the identified recommendations for improving access to maternal health. This model should consider factors such as the population size, healthcare infrastructure, and resources available in the specific context.

4. Input data and run simulations: Input the collected data into the simulation model and run multiple simulations to assess the potential impact of the recommendations. This could involve varying parameters such as the size of the pack, the design modifications, and the strategies for addressing inadvertent pregnancy disclosure.

5. Analyze results: Analyze the simulation results to determine the potential impact of the recommendations on improving access to maternal health. This could include assessing changes in the key indicators identified in step 1.

6. Refine recommendations: Based on the simulation results, refine the recommendations to optimize their impact on improving access to maternal health. This could involve iterating the simulation model and running additional simulations to test different scenarios.

7. Implement and monitor: Implement the refined recommendations in real-world settings and closely monitor the impact on access to maternal health. Continuously collect data and evaluate the outcomes to inform further improvements and adjustments.

By following this methodology, policymakers and healthcare providers can gain insights into the potential impact of innovations and make informed decisions to improve access to maternal health.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email